Clozapine Treatment for Schizophrenia
Clinical Uses and Monitoring
- The American Academy of Child and Adolescent Psychiatry recommends clozapine as a primary indication for treatment-resistant schizophrenia, defined as persistent moderate to severe delusions or hallucinations despite trials of at least two other antipsychotic medications 1, 2
- Regular monitoring of absolute neutrophil count (ANC) is required for patients taking clozapine, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 2
- Baseline and regular monitoring of complete blood counts with ANC is necessary for patients taking clozapine, according to the American Academy of Child and Adolescent Psychiatry 1, 2
- Documentation of target symptoms and treatment response is essential for patients taking clozapine, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 2
- Documentation of suspected side effects is crucial for patients taking clozapine, according to the American Academy of Child and Adolescent Psychiatry 1, 2